Exonate Company
Exonate is a biotech company spun out of the University of Nottingham that is focused on alternative splicing of (VEGF) in ophthalmology.
Technology:
Data-driven Technologies
Industry:
Gene therapy
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2013
Employees Number:
11-50
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Register and Claim Ownership